Rewiring of human lung cell lineage and mitotic networks in lung adenocarcinomas-Reference-Cited by-同舟云学术

Rewiring of human lung cell lineage and mitotic networks in lung adenocarcinomas

Published:2013-04-16 Issue:1 Volume:4 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Kim Il-Jin,Quigley David,To Minh D.,Pham Patrick,Lin Kevin,Jo Brian,Jen Kuang-Yu,Raz Dan,Kim Jae,Mao Jian-Hua,Jablons David,Balmain Allan

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/ncomms2660.pdf

Reference60 articles.

1. Edwards B. K. et al. Annual Report to the Nation on the Status of Cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 116, 544–573 (2010).

2. Delbaldo C. et al. Second or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced disease. Cochrane Database Syst. Rev. 17, CD004569 (2007).

3. Lynch T. J. et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N. Engl. J. Med. 350, 2129–2139 (2004).

4. Pao W. et al. Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain. PLoS Med. 2, e73 (2005).

5. Quigley D. A. et al. Genetic architecture of mouse skin inflammation and tumour susceptibility. Nature 458, 505–508 (2009).

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Dihydropteridinone Derivatives As Potent Inhibitors of the Understudied Human Kinases Vaccinia-Related Kinase 1 and Casein Kinase 1δ/ε;Journal of Medicinal Chemistry;2024-05-23

2. PEBP4 deficiency aggravates LPS-induced acute lung injury and alveolar fluid clearance impairment via modulating PI3K/AKT signaling pathway;Cellular and Molecular Life Sciences;2024-03-13

3. Loss of VRK1 alters the nuclear phosphoproteome in the DNA damage response to doxorubicin;Chemico-Biological Interactions;2024-03

4. SVM-DO: identification of tumor-discriminating mRNA signatures via support vectormachines supported by disease ontology;Turkish Journal of Biology;2023-12-28

5. Immune Infiltration in Tumor and Adjacent Non-Neoplastic Regions Codetermines Patient Clinical Outcomes in Early-Stage Lung Cancer;Journal of Thoracic Oncology;2023-09